Compare MD & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MD | HTFL |
|---|---|---|
| Founded | 1979 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Hospital/Nursing Management | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.5B |
| IPO Year | 1996 | N/A |
| Metric | MD | HTFL |
|---|---|---|
| Price | $23.40 | $29.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $20.50 | ★ $38.20 |
| AVG Volume (30 Days) | 723.6K | ★ 964.6K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 263.03 | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $1,913,849,000.00 | N/A |
| Revenue This Year | $3.72 | $27.66 |
| Revenue Next Year | $2.62 | $23.55 |
| P/E Ratio | $64.97 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.84 | $20.13 |
| 52 Week High | $24.99 | $41.22 |
| Indicator | MD | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 59.60 | 54.80 |
| Support Level | $20.64 | $28.60 |
| Resistance Level | $23.68 | $32.81 |
| Average True Range (ATR) | 0.95 | 1.55 |
| MACD | -0.01 | -0.26 |
| Stochastic Oscillator | 92.79 | 36.67 |
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.